Chinese Cancer Research Co. Lands $60M Funding
A Chinese biotechnology company said Tuesday it had landed $60 million to help it continue developing treatments for hematological tumors, certain stomach cancers and more....To view the full article, register now.
Already a subscriber? Click here to view full article